Implications of discontinuation of doxazosin arm of ALLHAT
- 1 March 2000
- journal article
- Published by Elsevier in The Lancet
- Vol. 355 (9207) , 863-864
- https://doi.org/10.1016/s0140-6736(00)00092-1
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Management of patients with hypertension and diabetes mellitus: advances in the evidence for intensive treatmentThe American Journal of Medicine, 2000
- Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 studyThe Lancet, 1999
- Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trialThe Lancet, 1999
- The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureArchives of internal medicine (1960), 1997
- Long-term Effects on Plasma Lipids of Diet and Drugs to Treat HypertensionJAMA, 1996
- Effects Morbidity of Treatment on in HypertensionJAMA, 1970